You just read:

RegeneRx to Receive EU Patent for Use of Tβ4 in Preventing And Treating Damage Associated with Reperfusion Injury

News provided by

RegeneRx Biopharmaceuticals, Inc.

06 Apr, 2016, 11:12 ET